Sun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance bridge loans taken for the Organon acquisition valued at $11.75 billion. The first tranche will amount to ₹7,000 crore with a coupon rate of 8.20%. Institutional investors are expected to participate, including notable companies like SBI Pension Fund and ICICI Prudential Mutual Fund.